vs

Side-by-side financial comparison of Freshworks Inc. (FRSH) and Bio-Techne (TECH). Click either name above to swap in a different company.

Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $222.7M, roughly 1.3× Freshworks Inc.). Freshworks Inc. runs the higher net margin — 86.0% vs 12.8%, a 73.1% gap on every dollar of revenue. On growth, Freshworks Inc. posted the faster year-over-year revenue change (14.5% vs -6.4%). Over the past eight quarters, Freshworks Inc.'s revenue compounded faster (16.1% CAGR vs 4.2%).

Freshworks Inc. is a cloud-based software-as-a-service company, founded in 2010 in Chennai, India. The company provides cloud-based tools for customer relationship management (CRM), IT service management (ITSM), and e-commerce marketing.

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

FRSH vs TECH — Head-to-Head

Bigger by revenue
TECH
TECH
1.3× larger
TECH
$295.9M
$222.7M
FRSH
Growing faster (revenue YoY)
FRSH
FRSH
+20.9% gap
FRSH
14.5%
-6.4%
TECH
Higher net margin
FRSH
FRSH
73.1% more per $
FRSH
86.0%
12.8%
TECH
Faster 2-yr revenue CAGR
FRSH
FRSH
Annualised
FRSH
16.1%
4.2%
TECH

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
FRSH
FRSH
TECH
TECH
Revenue
$222.7M
$295.9M
Net Profit
$191.4M
$38.0M
Gross Margin
85.6%
64.6%
Operating Margin
17.8%
18.4%
Net Margin
86.0%
12.8%
Revenue YoY
14.5%
-6.4%
Net Profit YoY
974.2%
68.3%
EPS (diluted)
$0.66
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRSH
FRSH
TECH
TECH
Q4 25
$222.7M
$295.9M
Q3 25
$215.1M
Q2 25
$204.7M
$317.0M
Q1 25
$196.3M
$316.2M
Q4 24
$194.6M
$297.0M
Q3 24
$186.6M
$289.5M
Q2 24
$174.1M
$306.1M
Q1 24
$165.1M
$303.4M
Net Profit
FRSH
FRSH
TECH
TECH
Q4 25
$191.4M
$38.0M
Q3 25
$-4.7M
Q2 25
$-1.7M
$-17.7M
Q1 25
$-1.3M
$22.6M
Q4 24
$-21.9M
$34.9M
Q3 24
$-30.0M
$33.6M
Q2 24
$-20.2M
$40.6M
Q1 24
$-23.3M
$49.1M
Gross Margin
FRSH
FRSH
TECH
TECH
Q4 25
85.6%
64.6%
Q3 25
84.7%
Q2 25
84.8%
62.7%
Q1 25
84.8%
67.9%
Q4 24
84.9%
65.3%
Q3 24
84.0%
63.2%
Q2 24
83.8%
66.4%
Q1 24
84.3%
67.4%
Operating Margin
FRSH
FRSH
TECH
TECH
Q4 25
17.8%
18.4%
Q3 25
-3.5%
Q2 25
-4.2%
-7.5%
Q1 25
-5.3%
12.2%
Q4 24
-12.2%
16.0%
Q3 24
-20.8%
13.8%
Q2 24
-25.1%
15.0%
Q1 24
-19.5%
22.1%
Net Margin
FRSH
FRSH
TECH
TECH
Q4 25
86.0%
12.8%
Q3 25
-2.2%
Q2 25
-0.8%
-5.6%
Q1 25
-0.7%
7.1%
Q4 24
-11.3%
11.7%
Q3 24
-16.1%
11.6%
Q2 24
-11.6%
13.3%
Q1 24
-14.1%
16.2%
EPS (diluted)
FRSH
FRSH
TECH
TECH
Q4 25
$0.66
$0.24
Q3 25
$-0.02
Q2 25
$-0.01
$-0.11
Q1 25
$0.00
$0.14
Q4 24
$-0.07
$0.22
Q3 24
$-0.10
$0.21
Q2 24
$-0.07
$0.26
Q1 24
$-0.08
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRSH
FRSH
TECH
TECH
Cash + ST InvestmentsLiquidity on hand
$781.4M
$172.9M
Total DebtLower is stronger
$260.0M
Stockholders' EquityBook value
$1.0B
$2.0B
Total Assets
$1.6B
$2.5B
Debt / EquityLower = less leverage
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRSH
FRSH
TECH
TECH
Q4 25
$781.4M
$172.9M
Q3 25
$813.2M
Q2 25
$926.2M
$162.2M
Q1 25
$995.3M
$140.7M
Q4 24
$1.1B
$177.5M
Q3 24
$1.1B
$187.5M
Q2 24
$1.0B
$152.9M
Q1 24
$1.2B
$145.3M
Total Debt
FRSH
FRSH
TECH
TECH
Q4 25
$260.0M
Q3 25
Q2 25
$346.0M
Q1 25
$330.0M
Q4 24
$300.0M
Q3 24
$300.0M
Q2 24
$319.0M
Q1 24
$389.0M
Stockholders' Equity
FRSH
FRSH
TECH
TECH
Q4 25
$1.0B
$2.0B
Q3 25
$851.5M
Q2 25
$984.6M
$1.9B
Q1 25
$1.1B
$2.0B
Q4 24
$1.1B
$2.1B
Q3 24
$1.1B
$2.1B
Q2 24
$1.1B
$2.1B
Q1 24
$1.1B
$2.0B
Total Assets
FRSH
FRSH
TECH
TECH
Q4 25
$1.6B
$2.5B
Q3 25
$1.4B
Q2 25
$1.5B
$2.6B
Q1 25
$1.5B
$2.6B
Q4 24
$1.6B
$2.7B
Q3 24
$1.6B
$2.7B
Q2 24
$1.5B
$2.7B
Q1 24
$1.5B
$2.7B
Debt / Equity
FRSH
FRSH
TECH
TECH
Q4 25
0.13×
Q3 25
Q2 25
0.18×
Q1 25
0.16×
Q4 24
0.14×
Q3 24
0.14×
Q2 24
0.15×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRSH
FRSH
TECH
TECH
Operating Cash FlowLast quarter
$62.3M
Free Cash FlowOCF − Capex
$60.1M
FCF MarginFCF / Revenue
27.0%
Capex IntensityCapex / Revenue
1.0%
Cash ConversionOCF / Net Profit
0.33×
TTM Free Cash FlowTrailing 4 quarters
$236.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRSH
FRSH
TECH
TECH
Q4 25
$62.3M
Q3 25
$63.5M
Q2 25
$58.6M
$98.2M
Q1 25
$58.0M
$41.1M
Q4 24
$41.4M
$84.3M
Q3 24
$42.3M
$63.9M
Q2 24
$36.3M
$75.5M
Q1 24
$40.6M
$81.0M
Free Cash Flow
FRSH
FRSH
TECH
TECH
Q4 25
$60.1M
Q3 25
$61.7M
Q2 25
$58.2M
$93.3M
Q1 25
$56.7M
$31.0M
Q4 24
$36.3M
$77.5M
Q3 24
$41.3M
$54.7M
Q2 24
$34.0M
$57.5M
Q1 24
$39.9M
$64.5M
FCF Margin
FRSH
FRSH
TECH
TECH
Q4 25
27.0%
Q3 25
28.7%
Q2 25
28.4%
29.4%
Q1 25
28.9%
9.8%
Q4 24
18.7%
26.1%
Q3 24
22.1%
18.9%
Q2 24
19.5%
18.8%
Q1 24
24.1%
21.3%
Capex Intensity
FRSH
FRSH
TECH
TECH
Q4 25
1.0%
Q3 25
0.8%
Q2 25
0.2%
1.5%
Q1 25
0.7%
3.2%
Q4 24
2.6%
2.3%
Q3 24
0.6%
3.2%
Q2 24
1.3%
5.9%
Q1 24
0.4%
5.4%
Cash Conversion
FRSH
FRSH
TECH
TECH
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
1.82×
Q4 24
2.42×
Q3 24
1.90×
Q2 24
1.86×
Q1 24
1.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRSH
FRSH

Subscription Services Software Licenses And Maintenance$220.2M99%
Professional Services$2.5M1%

TECH
TECH

Diagnostics And Spatial Biology$81.2M27%
EMEA Excluding UK$75.4M25%
Other$42.4M14%
Instruments$29.6M10%
APAC Excluding Greater China$22.7M8%
Services$22.3M8%
GB$13.7M5%
Royalty$8.5M3%

Related Comparisons